VICARIOUS SURGICAL INC RBOT
COM CL A NEW · Common Stock · CUSIP 92561V208
- SectorHealth care
- IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
- HeadquartersWaltham, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $6.94.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2024 | 35 |
| Q3 2024 | 35 |
| Q4 2024 | 31 |
| Q1 2025 | 32 |
| Q2 2025 | 31 |
| Q3 2025 | 32 |
| Q4 2025 | 36 |
| Q1 2026 | 8 |
| Q2 2026 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 17 | 19 |
| Q4 2024 | 9 | 11 |
| Q1 2025 | 11 | 11 |
| Q2 2025 | 10 | 8 |
| Q3 2025 | 13 | 12 |
| Q4 2025 | 15 | 13 |
| Q1 2026 | 0 | 28 |
| Q2 2026 | 0 | 8 |
Biggest buyers
| None |
Biggest sellers
| Aspex Management (HK) Ltd | Sold out | -86.7k |
| Forum Finance Group S.A. | Sold out | -3.3k |
| Rockefeller Capital Management L.P. | Sold out | -884 |
| Hughes Financial Services, LLC | Sold out | -333 |
| Daytona Street Capital LLC | Sold out | -100 |
| Federation des caisses Desjardins du Quebec | Sold out | -22 |
| SIGNATUREFD, LLC | Sold out | -16 |
| Sound Income Strategies, LLC | Sold out | -13 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
No one currently above 5% in the filings since 19 Dec 2024.
Fell to 5% or below in the last year: Innovation Endeavors III LP (3.4%, 2026-04-06)
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2024 | 0 | — | 4 | $32.9k | — |
| Q1 2025 | 0 | — | 3 | $38.0k | — |
| Q2 2025 | 0 | — | 2 | $20.1k | — |
| Q3 2025 | 0 | — | 3 | $44.5k | — |
| Q4 2025 | 0 | — | 2 | $6.1k | — |
| Q1 2026 | 0 | — | 2 | $3.5k | — |
| Q2 2026 | 0 | — | 0 | — | — |
| Q3 2026 | 0 | — | 0 | — | — |
None reported since 1 Apr 2026.
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| K5 Global Advisor LLC 0.00% of their portfolio | 720 $5.0k | First filing |